Search for: "Ortho McNeil Pharmaceutical LLC"
Results 1 - 20
of 41
Sorted by Relevance
|
Sort by Date
3 May 2010, 11:01 am
The District Court in Boston has posted the plea agreement and criminal Information filed against Ortho-McNeil Pharmaceutical, LLC, in the settlement announced last week by the Department of Justice. [read post]
29 Apr 2010, 2:06 am
The Department of Justice announced on April 29 that Ortho-McNeil Pharmaceutical, LLC, and Ortho-McNeil-Janssen Pharmaceuticals, Inc., two subsidiaries of Johnson & Johnson, have agreed to pay $81 million to settle charges brought in two whistleblower suits that they violated the False Claims Act by promoting Topamax for off-label (unapproved) uses. [read post]
20 Jul 2010, 12:56 pm
In April of 2010, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, both subsidiaries of Johnson & Johnson, agreed to pay over $81 million to settle criminal and civil liability claims arising from the illegal promotion of the drug Topamax. [read post]
2 May 2010, 6:32 pm
Ortho-McNeil Pharmaceutical LLC, agreed to pay a $6.14 mil criminal fine and plead guilty to a misdemeanor for misbranding Topamax in violation of the Food, Drug and Cosmetic Act. [read post]
13 May 2010, 4:57 pm
Two subsidiaries of Johnson & Johnson, Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., have agreed to pay more than $81 million to settle allegations that they violated the False Claims Act by illegally promoting the epilepsy drug, Topomax. [read post]
22 Sep 2009, 5:32 am
William Dowling filed a lawsuit Thursday against J&J and its units Ortho McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research and Development LLC. [read post]
22 Jul 2011, 12:06 am
She is suing Johnson & Johnson, Ortho-McNeil Pharmaceutical Inc. and Johnson & Johnson Pharmaceutical Research & Development LLC for negligence, breach of warranties and consumer fraud. [read post]
11 May 2010, 7:07 pm
The suit names Johnson & Johnson, Ortho-McNeil Pharmaceuticals Inc. and Johnson & Johnson Pharmaceutical Research and Development LLC as defendants to Presley's claim. [read post]
18 Nov 2011, 4:32 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
29 Apr 2010, 1:26 pm
The settlement arose from two whistleblower cases filed under federal and state False Claims Acts, alleging that Otho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, Inc., improperly marketed Topamax for psychiatric uses, when it was only FDA-approved to treat epilepsy. [read post]
29 Apr 2010, 1:26 pm
The settlement arose from two whistleblower cases filed under federal and state False Claims Acts, alleging that Otho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals, Inc., improperly marketed Topamax for psychiatric uses, when it was only FDA-approved to treat epilepsy. [read post]
2 Sep 2020, 1:45 pm
JOHNSON & JOHNSON d/b/a Alza Corporation, d/b/a Janssen Ortho LLC, d/b/a Janssen Research & Development LLC, d/b/a Ortho-McNeil Pharmaceuticals, Inc. [read post]
25 May 2010, 7:54 am
Ortho-McNeil Pharmaceutical LLC, 10-CR-10147, US District Court, District of Massachusetts (Boston). [read post]
17 Feb 2010, 8:00 am
(patent infringement) 1/8: Alza Corporation and Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
28 Aug 2009, 8:11 am
(patent infringement) 9/4: Purdue Pharma Products LP, Napp Pharmaceutical Group Ltd., Ortho-McNeil-Janssen Pharmaceuticals Inc. v. [read post]
21 Jun 2015, 6:17 pm
Por estas razones, se desestimaron las causas de acción y de igual manera las causas de acción bajo las leyes locales contra Johnson & Johnson Services, Inc., Janssen Cilag Mfg., LLC; Janssen Ortho, LLC. [read post]
21 Feb 2011, 7:46 am
In May of 2010, Ortho McNeil Pharmaceutical, LLC, a subsidiary of Johnson & Johnson, pled guilty in U.S. [read post]
26 Dec 2011, 1:02 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc. , No. 11-2070 (7th Cir. [read post]
29 Sep 2014, 11:59 am
Ortho-McNeil-Jannsen Pharmaceuticals, Inc., 2014 U.S. [read post]
28 Jul 2010, 12:06 am
(EDTexweblog.com) (Docket Report) US: Post-Bilski: Federal Circuit to reconsider diagnostic testing and medical methods – Prometheus v Mayo, Classen v Biogen (IP Spotlight) (Patently-O) US: Federal Circuit review of patent term extensions – Ortho-McNeil v Lupin, Photocure v Kappos (Patently-O) USPTO provides clarification regarding treatment of PTA letters (Patent Docs) US: Pharmaceutical reverse payments and lower drug costs: An interesting dilemma! [read post]
